PuraPharm Corp. Ltd. ( (HK:1498) ) just unveiled an announcement.
PuraPharm Corporation Limited reported its financial results for the year ending December 31, 2024, showing a revenue decline of 6.1% to HK$382,090,000 compared to the previous year. The company also reduced its net loss by 66.6% to HK$35,439,000, indicating improved financial management despite challenges in the Chinese medicine granule market, particularly in China.
More about PuraPharm Corp. Ltd.
PuraPharm Corporation Limited is a company incorporated in the Cayman Islands, operating primarily in the Chinese medicine industry. It focuses on the production and distribution of concentrated Chinese medicine granules, Chinese healthcare products, and operates Chinese medicine clinics under the brand Nong’s.
YTD Price Performance: 9.09%
Average Trading Volume: 78,824
Technical Sentiment Signal: Buy
Current Market Cap: HK$237M
See more data about 1498 stock on TipRanks’ Stock Analysis page.